DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $36.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target cut by Needham & Company LLC from $42.00 to $36.00 in a research note issued to investors on Friday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.

XRAY has been the subject of several other reports. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a report on Friday. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a neutral rating in a research note on Friday, January 12th. Barrington Research reaffirmed an outperform rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. StockNews.com upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research report on Friday, January 19th. Finally, Leerink Partnrs restated an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $35.22.

DENTSPLY SIRONA Stock Down 0.1 %

Shares of XRAY stock opened at $28.25 on Friday. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $41.65. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The firm has a 50-day moving average price of $32.02 and a 200 day moving average price of $32.69.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 earnings per share. On average, research analysts predict that DENTSPLY SIRONA will post 2.04 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.27%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in XRAY. VisionPoint Advisory Group LLC boosted its stake in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the period. Principal Securities Inc. bought a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Headlands Technologies LLC bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at approximately $30,000. Parkside Financial Bank & Trust boosted its position in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $47,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.